Skip to content

Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation

Pilot study for a new treatment of schizophrenia: a double-blind crossover transcranial magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN93378085
Enrollment
12
Registered
2007-09-28
Start date
2006-05-15
Completion date
Unknown
Last updated
2017-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Mental and Behavioural Disorders Schizophrenia

Interventions

12 patients will be randomly assigned to three different treatment conditions: 1. Prefrontal stimulation 2. Cerebellar stimulation 3. Placebo (sham) stimulation Magnetic stimulation (TBS) will occur

Sponsors

Record Provided by the NHSTCT Register - 2007 Update - Department of Health
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adult patients with schizophrenia (ages 18-55 years) 2. Patients will be screened with the Schedule for the Assessment of Negative Symptoms (SANS) (Andreasen, 1983). Patients with severe negative symptoms (defined by score of = 3 in any of SANS sub-scales) will be recruited for this study 3. All participants will be assessed for intelligence using the NART (Nelson, 1991) and handedness with Edinburgh Handedness Inventory (Oldfield, 1971)

Exclusion criteria

Exclusion criteria: 1. History of neurological disorder including seizures 2. General medical conditions likely to impair cortical function or haemodynamic response (hypertension or diabetes) 3. Metallic implants (and other contraindications to MR procedures) 4. Established drug or alcohol dependency disorders 5. Estimated IQ less than 75 6. Inability to give an informed consent

Design outcomes

Primary

MeasureTime frame
Regional functional brain response measured with functional magnetic resonance imaging (fMRI)

Secondary

MeasureTime frame
A variety of standardised psychiatric ratings and neuropsychological tests

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026